300485
vs
S
Shanghai Composite
300485
Over the past 12 months, Beijing Science Sun Pharmaceutical Co Ltd has outperformed Shanghai Composite, delivering a return of +42% compared to the Shanghai Composite's +31% growth.
Stocks Performance
300485 vs Shanghai Composite
Performance Gap
300485 vs Shanghai Composite
Performance By Year
300485 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Beijing Science Sun Pharmaceutical Co Ltd
Glance View
Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 584 full-time employees. The company went IPO on 2015-06-26. The Company' products can be divided into cardiovascular series, immune regulation series, nervous system series and other natural or biotech pharmaceuticals. Its products include small capacity injection and freeze-dried powder injection.